Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Drugmaker Apotex pays partners Bristol-Myers, Sanofi damages over premature generic Plavix
Yahoo/AP
Wednesday, February 8, 2012 - 11:44am
tags:
Sanofi, generics, Apotex, Bristol-Myers Squibb, Plavix
3 Biotech Companies Down But Not Out
Seeking Alpha
Wednesday, February 8, 2012 - 9:34am
tags:
Arena, Vivus, Orexigen, Biocryst, BioSante
Roche disappointed by Illumina bid rejection
Reuters
Wednesday, February 8, 2012 - 9:33am
tags:
Illumina, M&A, Roche
Can Amgen Convince Docs to Recommend Xgeva Approval?
Motley Fool
Wednesday, February 8, 2012 - 9:32am
tags:
Amgen, Xgeva, physicians, prostate cancer, FDA
Sanofi Q4 Earnings Rise On Emerging Markets Boost
NASDAQ.com
Wednesday, February 8, 2012 - 9:31am
tags:
earnings, Sanofi
Sanofi confirms 2012 earnings dip
Reuters
Wednesday, February 8, 2012 - 9:29am
tags:
Sanofi, earnings
Astex Falls Most Since 2004 as FDA Questions Drug
Bloomberg
Tuesday, February 7, 2012 - 6:05pm
tags:
FDA, Astex, Eisai, Dacogen
Threshold Pharmaceuticals: Up 150% In 4 Months With Room To Grow
Seeking Alpha
Tuesday, February 7, 2012 - 4:41pm
tags:
Threshold Pharmaceuticals, TH-302, hypoxia, pancreatic cancer
Illumina board rejects Roche's hostile offer
Marketwatch
Tuesday, February 7, 2012 - 4:39pm
tags:
Roche, Illumina, M&A, hostile bid
Three Big Reasons To Be Bullish On Pharma Stocks
Forbes
Tuesday, February 7, 2012 - 4:39pm
tags:
GSK will cut 3 R&D units, add 4 as DPU review triggers shakeup
Fierce Biotech
Tuesday, February 7, 2012 - 10:51am
tags:
R&D, reorganization, GSK
Orexigen surges on FDA trial pact for troubled weight loss drug
Fierce Biotech
Tuesday, February 7, 2012 - 10:50am
tags:
FDA, Orexigen, Contrave, obesity
6 Drug Stocks Unworthy of Biotech Bull Market
TheStreet.com
Tuesday, February 7, 2012 - 10:49am
tags:
Cytori, Regeneron, Human Genome Sciences, Galena Biopharma, BioSante, EntreMed
[video] Roche CEO on Illumina, DNA Sequencing, Euro Crisis
Marketwatch
Tuesday, February 7, 2012 - 10:41am
tags:
DNA sequencing, Roche, Illumina, Pharma CEOs, Severin Schwan
NeurogesX Shares Plunge After FDA Staff Says Pain Patch Might Not Work
Bloomberg
Tuesday, February 7, 2012 - 10:38am
tags:
NeurogesX, FDA, pain patches, Qutenza
Catalysts On Tap For Corcept Therapeutics
Seeking Alpha
Tuesday, February 7, 2012 - 10:37am
tags:
Corcept Therapeutics, Korlym, Cushing's syndrome, Corlux
White House Sides With Sales Reps On Overtime
Pharmalot
Tuesday, February 7, 2012 - 10:09am
tags:
overtime lawsuits, drug reps, Department of Labor, Supreme Court
GlaxoSmithKline back in profit in 4th quarter
Yahoo/AP
Tuesday, February 7, 2012 - 10:03am
tags:
earnings, GSK
GSK suspends four trials of Anacor antibiotic
Pharmaceutical Business Review
Tuesday, February 7, 2012 - 10:02am
tags:
GSK, Anacor, antibiotics
Merck clot drug meets study goal but bleeding a risk
Reuters
Tuesday, February 7, 2012 - 9:59am
tags:
Merck, Vorapaxar, anti-clotting

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.